AtriCure (ATRC) shares were up 8% in recent Monday trading after the company said it expects higher revenue for Q4 and fiscal 2024 from a year earlier.
The company said it expects Q4 revenue of $124.3 million, up about 17% from a year earlier.
Analysts polled by FactSet expect $120.4 million.
The company also said it predicts a 2024 revenue of $465.3 million, up 17% from 2023.
Analysts surveyed by FactSet expect $461.4 million.
AtriCure expects 2025 revenue of $517 million to $527 million.
FactSet analysts expect $522.2 million.
Price: 33.91, Change: +2.50, Percent Change: +7.96
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。